Category Specific RSS

News

Summer oysters trial tipped to increase Angel Seafood sales by 15%

Seafood-loving Australians could soon have access to a wider range of oysters year-round with Angel Seafood (ASX: AS1) set to commence a farming trial of summer oysters which, if successful, would enable them to deliver oysters throughout the calendar year.

The trials are part of Angel Seafood’s recently announced 3-pillar growth strategy to double their production capacity by capitalising on their resources and equipment to improve profitability.

By commencing the trial, it would give Angel a product for sale at time which is traditionally a spawning season for oysters, but also a peak period for demand.

“With demand for Angel oysters continuing to increase, this is an exciting next step for Angel as we continue to look at ways to grow capacity and increase profitability,” said Angel Seafood CEO and Founder, Zax Halman.

“The summer oysters trial means we can potentially supply one of the most celebrated products through the peak demand period.

“Being able to supply oysters to the retail market year-round will allow us to further cement our relationships in this channel, growing Angel’s reputation to guarantee supply of high-quality, organic oysters.”

The low-cost initiative will take place over the next 15 months with Angel to farm this trial on the Eyre Peninsula in South Australia. The first batch would be ready for sale around January 2022 and will be classified as an organically grown premium product.

By being able to supply oysters to the market year-round, Angel forecasts an increase to the sales by 10-15% annually and will utilise their recently leased water acquisitions that are expected to increase Angel’s production by 20% to more than 10 million oysters per annum.

For the Quarter ending 30 September 2020, Angel Seafood sold a record 2.7 million oysters for $2m in revenue, a 78% increase on the previous corresponding period, to deliver $408k positive cash flow.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

5 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago